Long-Term Debt: lavatherapeutics.com (LVTX)

Brandmark of LAVA Therapeutics NV (LVTX)

LAVA Therapeutics N.V. is developing innovative tumor-fighting methods through partnerships with global pharmaceutical behemoths, while a cohesive team of experts ensures shareholder confidence. This price chart on GURU.Markets illustrating trading dynamics shows that the separate_debt_long metric stands at 0.00. However, geopolitical fragmentation and logistical disruptions are hindering the procurement of biomaterials and the execution of the company's global research.

LVTX (LAVA Therapeutics) Company Long-Term Debt history from 07/04/2022 to 12/06/2025

LAVA Therapeutics - analytical breakdowns and key metrics (LVTX)

- current quotes and average value forecast:
Stock Quotes LAVA Therapeutics NV|LVTX - Price Target Chart
- company stock exchange capitalization indicators:
Market Value LAVA Therapeutics|LVTX - Total Company Value
- book capitalization data:
Net Assets per Single Share LAVA Therapeutics|LVTX - Company Book Value|Market-to-Book Ratio lavatherapeutics.com|LVTX - Company Total Assets
- debt level and financial liquidity data:
Debt to Capital Ratio LAVA Therapeutics N.V.|LVTX - Long-Term Debt to Equity Ratio|Current Liabilities to Capital LAVA Therapeutics NV|LVTX - Company Total Debt|Debt to Net Assets Ratio LAVA Therapeutics|LVTX - Company Long-Term Debts|Short-Term Debt Volume LAVA Therapeutics|Quick Liquidity Indicator lavatherapeutics.com
- net income and valuation multiples indicators:
LVTX - Company Net Income
Fundamental company valuation:LAVA Therapeutics N.V.
Core merchandise of lavatherapeutics.com

This indicator aggregates all liabilities with a maturity of over one year, allowing for an assessment of long-term financial stability and bankruptcy risk through liability dynamics. For LAVA Therapeutics N.V. (LVTX), which develops bispecific antibodies funded by partner payments, the business's low level of long-term debt confirms the effectiveness of a financing strategy for expansion without excessive credit leverage.

Who LAVA Therapeutics N.V. competes with

IBRX - Company Long-Term Liabilities|IMCR - Company Long-Term Debt|Long-Term Debt Janux Therapeutics Inc|Arcus Bio (RCUS) - Company Long-Term Debt|ZYME (Zymeworks Biopharmaceuticals) - Company Long-Term Debt|Company Long-Term Debt Tango Therapeutics|Long-Term Debt iovance.com IOVA|Company Long-Term Debts IMTX|Xencor Inc (XNCR) - Long-Term Indebtedness|Compass Bio - Company Long-Term Liabilities|Replimune Inc. (REPL) - Long-Term Debt|LYEL: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings IPHA (innate-pharma.com)|PYXS: Company Long-Term Debts|CGEN - Long-Term Debt Volume|Company Long-Term Debt IO Biotech Corp|Company Long-Term Liabilities Sutro Biopharma, Inc (STRO)|Company Long-Term Debt MiNK Therapeutics, Inc. (INKT)|Company Long-Term Liabilities werewolftx.com HOWL|Immix Biopharma - Company Long-Term Liabilities|Company Long-Term Debts alxoncology.com ALXO|CUE - Company Long-Term Debt|PDSB (PDS Biotechnology) - Company Long-Term Indebtedness|sonnetbio.com (SONN) - Company Long-Term Debt|Long-Term Debt MAIABiotech.com (MAIA)|Company Long-Term Liabilities LIMN|NXTC - Long-Term Indebtedness|Company Long-Term Liabilities LPTX (Leap Therapeutics, Inc.)|Amount of Long-Term Liabilities INTS|Company Long-Term Debts SNSE (Sensei Biotherapeutics, Inc.)|Company Long-Term Loans and Borrowings TOVX|Gritstone Bio - Company Long-Term Debts|Long-Term Debt Kineta Inc|NexImmune Corp (NEXI) - Company Long-Term Debt|Turnstone Biologics Corp. - Company Long-Term Loans and Borrowings|VCNX (Vaccinex, Inc.) - Company Long-Term Debts|Company Long-Term Debts harpoontx.com